Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma-Reference-Cited by-同舟云学术

Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma

Published:2021-02-01 Issue:3-4 Volume:32 Page:178-191
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Milenova Ioanna¹²,Lopez Gonzalez Marta¹,Quixabeira Dafne C.A.³,Santos Joao Manuel³⁴,Cervera-Carrascon Victor³,Dong Wenliang²,Hemminki Akseli³⁴,van Beusechem Victor W.¹,van de Ven Rieneke¹⁵,de Gruijl Tanja D.¹

Affiliation:

1. Departments of Medical Oncology and Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands

2. ORCA Therapeutics BV, ‘s-Hertogenbosch, The Netherlands

3. Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

4. TILT Biotherapeutics Ltd., Helsinki, Finland.

5. Departments of Otolaryngology/Head-Neck Surgery, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2020.277

Reference86 articles.

1. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

2. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

3. Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic Melanoma

4. Tumor-associated macrophages: an accomplice in solid tumor progression

5. The “cancer immunogram”

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells;Acta Pharmacologica Sinica;2024-07-19

2. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

3. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12

4. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions;Frontiers in Cellular and Infection Microbiology;2023-05-10

5. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05